Plunkett Research Online: Halozyme Therapeutics Inc

HALOZYME THERAPEUTICS INC (HALO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Halozyme Therapeutics, Inc. is a biopharmaceutical company dedicated to the development and commercialization of products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. To date, the firm has one product approved for sale in the U.S., Hylen.....



Halozyme Therapeutics Inc
Ticker: HALO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858-794-8889
Fax: 858-794-5370
Address: 11388 Sorrento Valley Road
San Diego, CA 92121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Helen TorleyCEO/Director/President
Laurie StelzerCFO/Chief Accounting Officer/Senior VP
See More
Halozyme Therapeutics, Inc. is a biopharmaceutical company dedicated to the development and commercialization of products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. To date, the firm has one product approved for sale in the U.S., Hylen.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: DLA Piper LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Hylenex
PEGPH20
HTI-1511
PEG-ADA 2
rHuPH20
ENHANZE
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: